Loading
BioSyent Inc. Stock: price and insider trades · Canada
BioSyent Inc.: what insiders have been doing
BioSyent Inc. belongs to the Health Care sector. Filings by its managers are published through SEDI. The last twelve months, up to 18 October 2026, brought 94 filings signed by 8 insiders.
Only sales appear on the open market, 31 sales in all totalling €238k, filed by 4 insiders. Biggest ticket of the year: €47k, sold by Goehrum, Rene and made public on 26 June 2026 (0.046% of market cap).
The median gap between a trade and its publication by SEDI is 3 days. This delay matters because a trade only becomes useful information once it is public. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
Compared with its exchange (2,121 companies, median 11 filings), a count of 94 filings is above the norm. Our records for BioSyent Inc. go back to 2026, with no purchases and 31 sales on the open market in total.
In the same sector, recent insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. also feature in our signals. Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
94
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€237,772
31 ops. · all time
Who traded when
BuySalePeter Douglas Lockhard15 sales
Seyed Ahmad Ashrafi14 sales
Rene Goehrum1 sale
Stephen Edwin William Wilton1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 2,605 of 24,148 companies
73.1
score / 100
Value56
Quality90
FCF yld4.8%
Earn yld5.0%
EV/EBITDA13.9x
ROE24%
Gross mgn77%
Net mgn21%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$17.15
Analyst consensus
1 analysts1.00/5
CA$18.00Target CA$18.00(+5%)CA$18.00
Income statement
RevenueCA$43.1M
Gross profitCA$33M77% margin
EBITDACA$12.9M30% margin
Net incomeCA$9M17.7% margin
Valuation
PER (trailing)20.2x
P/Book4.2x
Beta0.59
Balance sheet & cash
Market capCA$192.6M
Total debtCA$841.1k
Free Cash FlowCA$8.6M
Debt / Equity7%
Profitability & ownership
ROE23.7%
ROA15.9%
% insiders34.9%
% institutions4.1%
Last declaration on 7 October 2026
Declarations94 total
76,500 sharesCommon SharesTSXSEDI:4788962
75,000 shares@ CA$15.700.62% mcap36.8% of flowCommon SharesTSXSEDI:4788960
900 shares@ CA$15.650.0074% mcap0.4% of flowCommon SharesTSXSEDI:4788959
600 shares@ CA$15.650.0050% mcap0.3% of flowCommon SharesTSXSEDI:4788958
747 shares@ CA$16.500.0067% mcap15.1% of flowCommon SharesTSXSEDI:4786147
1,495 sharesCommon SharesTSXSEDI:4786146
345 shares@ CA$16.500.0031% mcap53.5% of flowCommon SharesTSXSEDI:4784624
691 sharesRights Restricted Share UnitsTSXSEDI:4784616
188 shares@ CA$16.500.0017% mcap53.4% of flowRightsTSXSEDI:4784475
376 sharesRightsTSXSEDI:4784472
1,000 shares@ CA$16.750.0090% mcap4.0% of flowCommon SharesTSXSEDI:4781481
2,900 shares@ CA$16.550.026% mcap11.4% of flowCommon SharesTSXSEDI:4781480
1,000 shares@ CA$16.350.0087% mcap3.9% of flowCommon SharesTSXSEDI:4781479
700 shares@ CA$16.200.0061% mcap2.7% of flowCommon SharesTSXSEDI:4781478
300 shares@ CA$16.050.0026% mcap1.1% of flowCommon SharesTSXSEDI:4781477
1,500 shares@ CA$15.850.013% mcap5.6% of flowCommon SharesTSXSEDI:4779290
1,300 shares@ CA$15.650.011% mcap4.8% of flowCommon SharesTSXSEDI:4776884
200 shares@ CA$15.690.0017% mcap0.7% of flowCommon SharesTSXSEDI:4776882
1,000 shares@ CA$15.650.0084% mcap3.7% of flowCommon SharesTSXSEDI:4776880
1,200 shares@ CA$16.000.010% mcap4.5% of flowCommon SharesTSXSEDI:4770027
500 shares@ CA$16.000.0043% mcap1.9% of flowCommon SharesTSXSEDI:4770025
1,500 shares@ CA$15.950.013% mcap5.6% of flowCommon SharesTSXSEDI:4770020
500 shares@ CA$15.850.0042% mcap1.9% of flowCommon SharesTSXSEDI:4770019
1,000 shares@ CA$15.700.0084% mcap3.7% of flowCommon SharesTSXSEDI:4770018
805 shares@ CA$15.8360.0068% mcap58.2% of flowCommon SharesTSXSEDI:4769779
25 of 94 declarations
About BioSyent Inc.
BioSyent Inc. is a Canadian company focused on the development and commercialization of pharmaceutical products. It aims to provide innovative solutions to enhance patient health.
